Security key
00653A107
Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY)
CUSIP: 00653A107
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / American Depositary Shares, each representing 6 Ordinary Shares
- Total 13F shares
- 151,690,402
- Total 13F value
- $144,141,106
- Share change
- -2,289,661
- Put/Call ratio
- 9.5%
- SEC-reported price per share
- $0.95
- Number of holders
- 79
- Value change
- -$2,309,667
- Number of buys
- 36
- Number of sells
- 26
- Shares outstanding
- 1,571,428,571
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
79
Top holders
10
ADAPY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Adaptimmune Therapeutics PLC SEC filings
Adaptimmune Therapeutics PLC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00653A107
Recent filing periods:
Ownership snapshot
Top reported holders of ADAPY - Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $37,995,933
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Matrix Capital Management Company, LP has the largest disclosed position value at $38M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Matrix Capital Management Company, LP's linked filing trail.
Disclosed position value
Top 5
Matrix Capital Management Company...
$38M
EcoR1 Capital, LLC
$26.72M
NEA Management Company, LLC
$16.65M
BAILLIE GIFFORD & CO
$14.77M
Long Focus Capital Management, LLC
$12.04M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
Company
|
—
denominator unverified
|
$37,995,933
38,974,185 shares
|
— | 30 Jun 2024 |
| EcoR1 Capital, LLC |
13F
Company
|
—
denominator unverified
|
$26,716,228
27,404,070 shares
|
— | 30 Jun 2024 |
| NEA Management Company, LLC |
13F
Company
|
—
denominator unverified
|
$16,651,076
17,079,778 shares
|
— | 30 Jun 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
denominator unverified
|
$14,768,958
15,149,203 shares
|
— | 30 Jun 2024 |
| Long Focus Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$12,036,522
12,346,417 shares
|
— | 30 Jun 2024 |
| PFM Health Sciences, LP |
13F
Company
|
—
denominator unverified
|
$10,256,173
10,520,231 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
79
Shares
151,690,402
Rows available
79
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
75
Q3 2024 holders
79
Holder diff
4
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend